News

Filter

Current filters:

AtriplaTruvada

1 to 9 of 29 results

New Zealand to fund Gilead's Atripla and Truvada

27-11-2012

New Zealand's Pharmaceutical Management Agency PHARMAC says that, effective December 1, it will fund…

Anti-viralsAsia-PacificAtriplaBiotechnologyFinancialGilead SciencesPharmaceuticalRegulationTruvada

Gilead HIV drugs Atripla and Truvada to be listed in New Zealand

13-11-2012

Following a consultation, New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval…

Anti-viralsAsia-PacificAtriplaBiotechnologyGilead SciencesPharmaceuticalPricingRegulationTruvada

Gilead's Quad non-inferior to Atripla for HIV; Truvada objections

08-03-2012

US biotech firm Gilead Sciences (Nasdaq: GILD) yesterday announced full Phase III clinical trial results…

Anti-viralsAtriplaBiotechnologyGilead SciencesNorth AmericaQuadRegulationResearchTruvada

Gilead Sciences subpoenaed in USA over HIV and other drugs

13-06-2011

US biopharmaceutical company Gilead Sciences (Nasdaq: GILD) revealed late Friday that it has received…

Anti-viralsAtriplaBiotechnologyGilead SciencesLegalNorth AmericaPharmaceuticalTruvada

AHF lambasts Gilead over HIV drug price hikes

06-04-2011

The USA-based AIDS Healthcare Foundation (AHF), the largest global AIDS organization, blasted the news…

Anti-viralsAtriplaEmtrivaGilead SciencesNorth AmericaPharmaceuticalPricingTruvada

1 to 9 of 29 results

COMPANY SPOTLIGHT

Menarini

Back to top